Lin Patrick Insider Trades

Insider Trading History

Track insider trading activity for Lin Patrick. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $21.3k 7,594 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.07k 1,369 shares
$2.97
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $17.5k 6,236 shares
Last Trade
Apr 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.06k 1,511 shares
$2.69
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $13.2k 4,725 shares
Last Trade
Apr 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.07k 1,369 shares
$2.97
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $9.4k 3,356 shares
Last Trade
Mar 31, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.07k 1,603 shares
$2.54
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $0 0 shares
Last Trade
Jan 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$556 193 shares
$2.88
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $4.91k 1,753 shares
Last Trade
Jan 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$556 193 shares
$2.88
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $571k 204,000 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.8k 204,000 shares
$0.20
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $3.95M 1,412,082 shares
Last Trade
Jul 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$352k 1,401,650 shares
$0.25
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $122k 43,541 shares
Last Trade
Apr 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.97k 14,482 shares
$0.41
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $108k 38,727 shares
Last Trade
Apr 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.97k 4,814 shares
$0.41
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $122k 43,500 shares
Last Trade
Jan 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.4k 65,250 shares
$0.65
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $122k 43,500 shares
Last Trade
Jan 27, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.6k 43,500 shares
$0.61
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $81.4k 29,059 shares
Last Trade
Jul 10, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.6k 271 shares
$42.75
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $82.1k 29,330 shares
Last Trade
Jul 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.5k 644 shares
$42.75
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $80.3k 28,686 shares
Last Trade
Apr 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$37.6k 539 shares
$69.75
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $81.8k 29,225 shares
Last Trade
Apr 05, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$117k 1,675 shares
$69.75
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $76.9k 27,478 shares
Last Trade
Feb 01, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.6k 1,500 shares
$2.40
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $72.7k 25,978 shares
Last Trade
Jan 31, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.93k 2,500 shares
$2.37
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $56.4k 20,132 shares
Last Trade
Jan 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.2k 1,675 shares
$6.69
$2.80
Processa Pharmaceuticals
Processa Pharmaceuticals PCSA
Chief Business - Strategy Off
Holding Value $80.1k 28,614 shares
Last Trade
Jan 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.61k 539 shares
$6.69
$2.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up